Question:
The composition of "Lindlar catalyst" is:
The composition of "Lindlar catalyst" is:
Show Hint
The Lindlar catalyst is specifically used for the partial hydrogenation of alkynes, and its composition includes palladium supported on calcium carbonate.
Updated On: Feb 4, 2025
- Amalgamated Zinc and HCl
- NH2NH2 and KOH
- Palladium with calcium carbonate
- Palladium with Sodium carbonate
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The Lindlar catalyst is composed of palladium (Pd) supported on calcium carbonate (CaCO₃). It is commonly used for the hydrogenation of alkynes to cis-alkenes, and it is a key catalyst in selective hydrogenation reactions.
Was this answer helpful?
0
0
Top Questions on Stability of formulated products
- According to the ICH guidelines for stability studies, Climatic Zone II temperature and relative humidity are respectively:
- GPAT - 2025
- Pharmaceutics
- Stability of formulated products
- The most suitable test for digitoxose is:
- GPAT - 2024
- Pharmaceutics
- Stability of formulated products
- The composition of "Lindlar catalyst" is:
- GPAT - 2024
- Pharmaceutics
- Stability of formulated products
- The most suitable test for digitoxose is:
- GPAT - 2024
- Pharmaceutics
- Stability of formulated products
- Noye-Whitney’s equation predicts:
- GPAT - 2023
- Pharmaceutics
- Stability of formulated products
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
- Common name of convective transport
- GPAT - 2025
- Pharmaceutical Analysis
- Which of the following is commonly used as a broad-spectrum preservative in pharmaceutical formulations?
- GPAT - 2025
- Pharmaceutical Analysis
View More Questions